Overview

Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of high dose clopidogrel as the antiplatelet therapy on inhibition of platelet aggregation in Japanese patients scheduled for percutaneous coronary intervention due to ischemic heart disease.
Phase:
Phase 4
Details
Lead Sponsor:
Takeshi Morimoto
Treatments:
Clopidogrel
Ticlopidine